Lashkarbolouk Narges, Mazandarani Mahdi, Mohajeri Tehrani Mohammad Reza, Aalaa Maryam, Sanjari Mahnaz, Mehrdad Neda, Reza Amini Mohammad
Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Evidence Based Medicine Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Clin Med Insights Endocrinol Diabetes. 2023 Jul 27;16:11795514231189048. doi: 10.1177/11795514231189048. eCollection 2023.
Diabetes is a chronic disease that challenges global health issues in many aspects. Diabetic foot ulcer (DFU) is one of the most common causes of reduced quality of life and increased hospitalization, amputation, treatment costs, and mortality in patients. Improper patients' knowledge, unsatisfactory education and training of healthcare workers, and limited facilities are the major cause of delayed referral and downscale management in DFUs. The diabetic foot clinical pathway is pivotal in providing best practices based on the latest standards and patient preferences. In the diabetic foot clinical pathway provided by the Iran Ministry of Health, the common concepts and grading systems are well defined for diabetic foot specialists so that patients can be diagnosed correctly and referred properly. Based on clinical examination guidelines, patients with diabetes are classified into low-risk, moderate-risk, high-risk, and active diabetic foot ulcer groups. One of this Pathway's main objectives is to prevent the patient from getting the first ulcer, prevent frequent recurrence ulcers, and most importantly, prevent minor and major amputation.
糖尿病是一种在诸多方面对全球健康问题构成挑战的慢性疾病。糖尿病足溃疡（DFU）是导致患者生活质量下降、住院率增加、截肢、治疗费用上升及死亡率升高的最常见原因之一。患者知识欠缺、医护人员教育与培训不尽人意以及设施有限是DFU延迟转诊和降级管理的主要原因。糖尿病足临床路径对于依据最新标准和患者偏好提供最佳实践至关重要。在伊朗卫生部提供的糖尿病足临床路径中，针对糖尿病足专科医生明确界定了常见概念和分级系统，以便能正确诊断患者并进行恰当转诊。根据临床检查指南，糖尿病患者被分为低风险、中风险、高风险和活动性糖尿病足溃疡组。该路径的主要目标之一是防止患者首次出现溃疡，预防溃疡频繁复发，最重要的是，预防大小截肢。
